HIV: New York City patient adherent to PrEP positive with virus - Outbreak News Today | Outbreak News Today Outbreak News Today
Subscribe: RSS Twitter

The New York City Department of Health and Mental Hygiene advised health care providers in an alert Thursday of a case of HIV infection in a resident who was reported to have been adherent to HIV pre-exposure prophylaxis (PrEP).

Red-colored H9-T cell that had been infected by numerous, spheroid-shaped, mustard-colored human immunodeficiency virus (HIV) particles Image/NIAID

Red-colored H9-T cell that had been infected by numerous, spheroid-shaped, mustard-colored human immunodeficiency virus (HIV) particles
Image/NIAID

Health officials say the patient has  a multidrug resistant strain of the virus, including resistance to the drugs in PrEP.

Evidence of PrEP adherence was demonstrated by sufficient drug levels in hair and blood samples were detected a few weeks after the time of the HIV diagnosis.

NYC health officials note that the medication approved for PrEP, Truvada, is highly effective at preventing HIV infection, but rare episodes of HIV infection are still possible and expected.

The Health Department requests that providers report immediately by phone any HIV diagnosis in a person receiving PrEP or HIV post-exposure prophylaxis (PEP) because of the elevated risk of drug resistant HIV infection.

Related: 

1 Comment

  1. […] The New York City Department of Health and Mental Hygiene advised health care providers in an alert Thursday of a case of HIV infection in a resident who was reported to have been adherent to HIV pre-exposure prophylaxis (PrEP). Health officials say the patient has  a multidrug resistant strain of the virus, including resistance to the drugs […] US News – Outbreak News Today […]

Leave a Reply

© 2016 Outbreak News Today · Subscribe: RSS Twitter ·